AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹4,829 Cr | ₹4,504 Cr | ₹4,705 Cr | ₹4,197 Cr | ₹4,109 Cr |
What is the latest Total Liabilities ratio of AJANTA PHARMA ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹4,829 Cr |
Mar2024 | ₹4,504 Cr |
Mar2023 | ₹4,705 Cr |
Mar2022 | ₹4,197 Cr |
Mar2021 | ₹4,109 Cr |
How is Total Liabilities of AJANTA PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹4,829 Cr | 7.21 | |
Mar2024 | ₹4,504 Cr | -4.27 | |
Mar2023 | ₹4,705 Cr | 12.10 | |
Mar2022 | ₹4,197 Cr | 2.14 | |
Mar2021 | ₹4,109 Cr | - |
Compare Total Liabilities of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹31,797.0 Cr | -0.2% | -5% | -19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -0.2% |
-5% |
-19.2% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses